Christopher O'Donnell
InvestorFounderVice President, WWBD / Partner at Pfizer Venture Investments · Board director at Strata Oncology
Connecticut
Writes $100K – $15M checks · typically $10M
FoundedStrata Oncology
About
Christopher O'Donnell is a Partner and Vice President at Pfizer Ventures and a Board Member at Cartography Biosciences. He holds a B.S. in Chemistry from the University of Illinois and a Ph.D. in Organic Chemistry from the University of Wisconsin, Madison, with postdoctoral experience in synthetic chemistry at UC Irvine. At Pfizer, where he joined in 1999, O'Donnell has held roles as medicinal chemist, project leader, and manager, contributing to the discovery of clinical candidates in neuroscience programs and building the Antibody Drug Conjugate chemistry group in 2010, which has nominated fourteen conjugates for clinical development with seven entering clinical trials; he subsequently established the Applied Synthesis Technologies group in 2017 and is an author on over 50 publications and inventor on more than 20 patents.
Board director at Strata Oncology
Intro paths
In turn, Christopher can intro founders to Strata Oncology's investors below.
Strata Oncology's investors · 5
Co-founders at Strata Oncology
Experience
- Cartography BiosciencesBoard Membercurrent2026 — present
- TRexBioBoard Membercurrent2026 — present
- Enlaza TherapeuticsBoard Observercurrent2024 — presentLa Jolla, California
- Arrakis TherapeuticsMember Board Of Directorscurrent2021 — present
- PfizerVice President - Business Development and Partner, Pfizer Venturescurrent2022 — presentNew York, United States
- PfizerPartner, Pfizer Ventures & Executive Director, Emerging Sciences & Innovationcurrent2020 — present
- PfizerExecutive Director, External Sciences & Innovation & Principal, Pfizer Ventures2018 — 2020
- PfizerExecutive Director, Applied Synthesis Technology2016 — 2018Groton, CT
- PfizerExecutive Director, Oncology Medicinal Chemistry2015 — 2016Groton, CT
- PfizerSenior Director, Oncology Medicinal Chemistry2010 — 2015Groton, CT
- PfizerSenior Director, Neuroscience Medicinal Chemistry2009 — 2010Groton, CT
- PfizerDirector, Neuroscience Medicinal Chemistry2007 — 2008Groton, CT
- PfizerAssociate Director, Neuroscience Medicinal Chemistry2006 — 2007Groton, CT
- PfizerProject Team Lead, Neuroscience Medicinal Chemistry2006 — 2007Groton, CT
- PfizerSenior Principal Scientist, CNS Medicinal Chemistry2004 — 2006Groton, CT
- PfizerSenior Research Scientist, CNS Medicinal Chemistry2001 — 2004Groton, CT
- PfizerResearch Scientist, CNS Medicinal Chemistry1999 — 2001Groton, CT
- Pyxis OncologyTechnical Advisory Boardcurrent2022 — present
- TRIANA BiomedicinesMember Board Of Directorscurrent2022 — present
- MindImmune Therapeutics, Inc.Member Board of Directorscurrent2022 — presentSouth Kingston, RI
Education
- UC IrvinePost Doc, Organic Chemistry
- University of Wisconsin-MadisonPhD, Organic Chemistry
- University of Illinois Urbana-ChampaignBachelor of Science - BS, Organic Chemistry
Skills & more
+12 more
BiotechnologyClinical DevelopmentLead ChangeADMEDMPKOrganic ChemistryHPLCChromatographyLife SciencesBiomarkersLC-MSDrug MetabolismFrom Christopher's professional profile.
Colleagues at Pfizer Venture Investments
Network4
Investors connected to Christopher in public investor directories — a warm-intro map.
Frequently asked questions
- Where does Christopher O'Donnell work?
- Christopher O'Donnell is Vice President, WWBD / Partner at Pfizer Venture Investments and Founder at Strata Oncology.
- What check size does Christopher O'Donnell write?
- Christopher O'Donnell typically writes checks of $100K – $15M.
- What companies did Christopher O'Donnell found?
- Christopher O'Donnell founded Strata Oncology.
Same school
Also attended UC Irvine117
+ 111 more
Also attended University of Wisconsin-Madison240
+ 234 more
Also attended University of Illinois Urbana-Champaign392
+ 386 more




































%20(1).png)



















